Jeanne Lenzer is a medical investigative journalist and regular contributor to the British medical journal, BMJ. Her work has appeared in The Atlantic, Discover, The New Republic, The American Prospect, USA Today, Newsweek Japan and many other outlets. She was a fellow in the Knight Science Journalism program at MIT in 2006-2007.

She has published investigative reports on several highly contentious topics, including a report with Shannon Brownlee challenging claims by the Center for Disease Control and Prevention regarding the dangers of H1N1 flu; the vaccine used to prevent flu, and the main drug used to treat flu (The Atlantic). In 2005, she wrote an investigative report about antidepressants, published by BMJ, that led Eli Lilly, Inc. – the manufacturer of fluoxetine (Prozac) – to spend roughly $1 million in an attack on Ms. Lenzer, her article, and her publisher. She reports that she is still alive and well today.

Lenzer and her collaborator, Shannon Brownlee, just published a feature in the New York Times Magazine, Can Cancer Ever Be Ignored, which examined the problems with the PSA test for prostate cancer. In November of 2009, she and and Brownlee published a feature story about the flu vaccine titled, Does the Vaccine Matter?

Prior to the panel, Lenzer and I spoke at length about her work on the cancer screening story as well as her experience being sued by Eli Lilly. This was the longest interview of the bunch, and due to a (fixable) technical issue I won’t have the audio edited before the panel. But I’ll post it here soon. It’s worth waiting for.